^
    1year
    NeoGenomics expands NGS portfolio with launch of Neo Comprehensive - Solid Tumor CGP and Neo Comprehensive - Myeloid Disorders CGP (NeoGenomics Press Release)
    "NeoGenomics, Inc...announced today the expansion of their next-generation sequencing (NGS) portfolio of innovative products with the commercial availability of multiple tests, including Neo Comprehensive - Solid Tumor, a comprehensive genomic profile (CGP) for solid tumor cancers, and Neo Comprehensive - Myeloid Disorders, a CGP for myeloid neoplasms."
    Launch • Commercial
    |
    Neo Comprehensive - Myeloid Disorders Assay • Neo Comprehensive - Solid Tumor Assay